[ACC] Should Gene Editing Technologies Be Used In Humans?

2019 Adversarial Collaboration Contest entry (Nita J & Patrick N) surveying whether gene-editing should be used in humans. Covers CRISPR mechanics, safety/efficacy (off-target and linked-gene edits, the P53/cancer-risk Nature Medicine findings, germline-modification stakes), the He Jiankui CRISPR-twins scandal, heterozygote advantage / balancing selection, and a sustained case against genetic determinism: GWAS over-sample WEIRD populations and yield mostly weak correlative gene-disease links, the exposome and epigenetics (DNA methylation, 'genes load the gun, environment pulls the trigger,' even leaky-gut) mean gene EXPRESSION matters more than sequence, and cancer depends on the tumor microenvironment. Concludes editing should be a tightly-governed last resort for single-gene diseases, not enhancement.

Quality 63 · Strong. Strong floor (63). A scientifically literate, broad, well-sourced explainer with a coherent anti-genetic-determinism thread. Held at the low end of Strong: for an 'adversarial' collaboration the both-sides synthesis is under-realized (it largely argues one direction), it leans on some contested/fringe-adjacent sources (Bredesen's Alzheimer's reversal, Fasano's leaky-gut-causes-everything) a bit uncritically, and it is more literature-review than incisive analysis, never firmly answering its title question. Below the Islam ACC (67) for the softer thesis and narrower scope.

Claude’s paradigm shift 40 · Moderate. Moderate (40). Synthesizes well-established science (CRISPR, GWAS critiques, epigenetics); the anti-determinism framing is itself standard. Low novelty in its moment.

Real-world impact 2 · Minor. 2 -- minor/within-blog. A guest contest entry on a hugely consequential topic, but its own footprint is small-community/within-blog.